LYRA THERAPEUTICS INC
LYRA
LYRA was delisted on the 16th of March, 2026.
51 hedge funds and large institutions have $9.06M invested in LYRA THERAPEUTICS INC in 2024 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 42 closing their positions.
8% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 13
0.45% less ownership
Funds ownership: 1.53% → 1.07% (-0.45%)
35% less funds holding
Funds holding: 78 → 51 (-27)
64% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 42
97% less capital invested
Capital invested by funds: $283M → $9.06M (-$274M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.06M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.23M |
| 3 |
Morgan Stanley
New York
|
+$1.69M |
| 4 |
Two Sigma Advisers
New York
|
+$1.22M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$981K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$17.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$17.1M |
| 3 |
VA
VR Adviser
New York
|
-$16M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$8.79M |
| 5 |
ABG
Ally Bridge Group
New York
|
-$6.24M |
LYRA Hedge Fund Activity: Q2 2024 in Review
51 of the 6,926 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q2 2024, worth a combined $9.06M — down 97% from $283M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of LYRA and 15 opened new positions — a net loss of 27 holders — while 13 trimmed existing stakes and 14 added.
The largest buyer was BlackRock, adding an estimated $6.06M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $17.5M sold.
- 51 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q2 2024, down from 78 in Q1 2024.
- Funds reported $9.06M of LYRA THERAPEUTICS INC stock for Q2 2024, down 97% quarter-over-quarter.
- 15 funds opened new LYRA THERAPEUTICS INC positions in Q2 2024 and 42 closed out, a net change of -27 holders.
- The largest LYRA THERAPEUTICS INC buyer in Q2 2024 was BlackRock, an estimated $6.06M added.
- The largest LYRA THERAPEUTICS INC seller in Q2 2024 was Nantahala Capital Management, an estimated $17.5M sold.
Based on aggregated 13F filings for Q2 2024.